Gregor Obernosterer

Sequencing Solutions, Roche Diagnostics | Portfolio Management, RoX Health

Berlin, Berlin, Germany

About

I thrive where science, business, and human need meet. As a strategic shaper with a bias for action, I turn complex ideas into solutions that create real-world impact. At Roche Diagnostics Germany, I lead key genomics accounts with full commercial responsibility, driving adoption of advanced sequencing technologies — from NGS and the AXELIOS sequencer. My focus: turning scientific innovation into market success. In parallel, I lead portfolio management at RoX Health, Roche’s digital health venture builder. There, I help shape and scale ventures that push healthcare forward with speed, clarity, and commercial rigor. Spanning both genomics and digital health, I bridge innovation and execution — building what’s next, and making it work in the real world.

Experience

  • Roche (14 yrs 6 mos)
    • Strategic Partnerships Lead Sequencing Solutions
      Jan 2021 - Present · 5 yrs 6 mos

    • Oncology Innovation Manager
      Jan 2019 - Dec 2020 · 2 yrs

    • Sr. Account Manager Sequencing Solutions
      Jan 2017 - Dec 2018 · 2 yrs

  • RoX Health (5 yrs 6 mos)
    • Head of Portfolio Management - Driving RoX as Roche’s Early Innovation Engine
      Oct 2025 - Present · 9 mos

    • Sr. Innovation Lead
      Jul 2022 - Nov 2025 · 3 yrs 5 mos

    • Director Business Development
      Jan 2021 - Jun 2022 · 1 yr 6 mos

  • Postdoctoral Fellow at The Netherlands Cancer Institute
    2010 - 2011 · 1 yr

  • Postdoctoral Fellow at Whitehead Institute
    2009 - 2010 · 1 yr

  • CSSS at Santa Fe Institute
    2007 - 2007 · Less than a year